Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
<p>Abstract</p> <p>Background</p> <p>Basal-like breast cancer has been extensively characterized on the basis of gene expression profiles, but it is becoming increasingly common for these tumors to be defined on the basis of immunohistochemical (IHC) staining patterns, particularly in retrospective...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2007-07-01
|
| Saila: | BMC Cancer |
| Sarrera elektronikoa: | http://www.biomedcentral.com/1471-2407/7/134 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|